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The Family Longevity Selection Score (FLoSS) was used to select families for the Long
Life Family Study (LLFS) but has never been validated in other populations. The goal
of this paper is to validate how well the FLoSS-based selection procedure works in
an independent dataset. In this paper, we computed FLoSS using the lifespan data of
234,155 individuals from a large comprehensive genealogically-based resource, the Utah
Population Database (UPDB), born between 1779 and 1910 with mortality follow-up
through 2012–2013. Computations of FLoSS in a specific year (1980) confirmed the
survival advantage of the “exceptional” sibships (defined by LLFS FLoSS threshold,
FLoSS ≥ 7). We found that the subsample of the UPDB participants born after 1900
who were from the “exceptional” sibships had survival curves similar to that of the US
participants from the LLFS probands’ generation. Comparisons between the offspring
of parents with “exceptional” and “ordinary” survival showed the survival advantage
of the “exceptional” offspring. Investigators seeking to explain the extent genetics and
environment contribute to exceptional survival will benefit from the use of exceptionally
long-lived individuals and their relatives. Appropriate ranking of families by survival
exceptionality and their availability for the purposes of providing genetic and phenotypic
data is critical for selecting participants into such studies. This study validated the FLoSS
as selection criteria in family longevity studies using UPDB.
Keywords: exceptional survival, familial longevity, Long Life Family Study, Utah population database, family
longevity selection score
INTRODUCTION
Exceptional survival is a combined outcome of many factors such as genetics, life style, and
environmental exposures. Studying exceptionally long-lived individuals and their relatives in family
longevity studies can help explain the extent that genetics and environment contribute to this trait.
Selecting participants into such studies can be challenging because exceptional survivors represent
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a small fraction of a general population and, in addition, the
studies often need to enroll living siblings (who can provide
essential epidemiological, demographic, and biospecimen data)
who should for practical reasons reside within the study area
(also of note, there must be any siblings before there can be
long lived siblings—hence the recruitment for exceptional
longevity among siblings is a function of cohort fertility).
In addition, the definition of “exceptionality” of familial
longevity is important for constructing specific procedures
for identifying the truly “exceptional families” enriched
for longevity while ensuring a sample size with adequate
power.
Sebastiani et al. (1) developed the Family Longevity Selection
Score (FLoSS). This score was used to select the families for
the Long Life Family Study (LLFS). It takes into account both
exceptionality of family members’ survival and the presence
of very old living family members. The necessary information
can be collected from living family members and used to
compute the score. The selection procedure assumes that
FLoSS generated from scores reflecting exceptional survival of
individual family members will identify “exceptional” families.
However, there is no “direct” way to test whether the resulting
LLFS sample has better survival in relation to a general
population.
In LLFS, all selected individuals were alive at the time
of enrollment and a subsample of those survived until the
end of the follow up period. This means that lifespan data
for these surviving individuals are incomplete (right censored
and left truncated). Therefore, “direct” testing for exceptional
longevity of selected individuals would require additional time
in order to see the cohorts become extinct. To test whether
the procedure used for selecting LLFS participants identifies
individuals with exceptional longevity, one can apply the
same computational procedure using FLoSS to individuals
in birth cohorts who have complete information about their
lifespans. This allows one to determine whether survival
functions for “exceptional” (“selected”) individuals are superior
to those in the general population comprising individuals from
the same birth cohorts but who were not selected by this
procedure.
The goal of this paper is to validate how well the FLoSS-
based selection procedure performs in an independent dataset.
Here, we present results where we compute FLoSS using the
lifespan data for a sample from the Utah Population Database
(UPDB). This database is widely used for population-based
analyses of familial risk and genetic susceptibilities that allow
researchers to estimate the heritability of longevity and other
phenotypes and identify predisposition genes responsible for
the extreme life span (2, 3). In our application, these data
provide the unique opportunity to test the hypothesis that
the score used for LLFS recruitment identifies families with
exceptional longevity by computing FLoSS based on data
on lifespans of UPDB family members and comparing the
survival curves of the “exceptional” and “ordinary” longevity
UPDB subjects (as defined by the FLoSS thresholds similar to
LLFS).
MATERIALS AND METHODS
Characteristics of UPDB Subsample Used
to Calculate FLoSS
This study utilizes data drawn from the Utah Population
Database (UPDB). The UPDB is one of the world’s richest sources
of linked population-based information for demographic,
genetic, and epidemiological studies. UPDB has supported
numerous biomedical investigations in large part because of
its size, inclusion of multi-generational pedigrees, and linkages
to numerous data sources. The UPDB now contains data on
over 11 million individuals from the late eighteenth century
to the present and is representative of Utah’s population. The
holdings of the data grow due to longstanding efforts to update
records as they become available including statewide birth and
death certificates, hospitalizations, ambulatory surgeries, and
driver licenses. UPDB creates and maintains links between
the database and the medical records held by the two largest
healthcare providers in Utah as well as Medicare claims. The
multigenerational pedigrees representing Utah’s founders and
their descendants were constructed based on data provided by
the Genealogical Society of Utah (GSU). Pedigrees spanning the
past 80 years have been expanded extensively based on vital
records and, together with the GSU data, form the basis of the
deep genealogical structure of the UPDB (2, 4, 5). This study
has been approved by the University of Utah’s Resource for
Genetic and Epidemiologic Research and its Institutional Review
Board.
The subset of the UPDB available for this study (referred
to as the “UPDB sample” throughout the text) contains
information on individuals from UPDB families that fulfill
the following requirements: (1) an individual and all siblings
are born in 1910 or earlier; (2) an individual and all
siblings have information on a year of birth and a year of
death or a last living year; (3) an individual’s mother and
father have information on birth and death years or a last
living year. The resulting sample contains 400,822 individuals
born between 1779 and 1910 with follow-up data through
2012–2013. Among them, 326,023 individuals have known
information about lifespan (computed as year of death minus
year of birth), with the remainder having a last known living
year.
Computation of FLoSS in UPDB Sample
The methodology for calculating FLoSS in LLFS is described in
detail in Sebastiani et al. (1) (see also Supplementary Material).
We computed FLoSS in the UPDB sample by adopting this
methodology. In Sebastiani et al. (1), exceptional longevity of
individuals was calculated based on birth year- and gender-
specific cohort survival probabilities from the US Social Security
Administration (SSA) cohort life tables. Since such life tables are
not available for cohorts earlier than 1900, in this analysis we
constructed gender-specific cohort life tables (for 10-year birth
cohorts) using available lifespan data from the UPDB sample.
All individuals born before 1850 were grouped into one cohort
due to its modest sample size. We excluded adopted siblings
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and family members who died before age 40, similar to the
restriction used with the LLFS procedure. The resulting sample
(“UPDB-All”) contained 234,155 individuals. These conditional
(at age 40) cohort life tables from the UPDB sample were
used for calculation of FLoSS as described in Sebastiani et al.
(1). We constructed different subsamples from the UPDB-All
sample relevant for our analyses as described below (see also
Supplementary Table 1).
We used the same threshold as in LLFS (FLoSS ≥ 7) to select
exceptional sibships in our study (the “UPDB-FLoSS” sample).
In LLFS, this threshold was chosen because it was determined
that such families are rare but are still detectable with sufficient
frequency (1). In our applications, this threshold corresponds
approximately to the highest 2.2% of the FLoSS distribution
among the UPDB participants born after 1900 (referred to as the
“UPDB-1900” sample; the subset of this sample with FLoSS ≥ 7
is denoted as the “UPDB-1900-FLoSS” sample). This particular
year was selected as one of the earliest birth cohorts in LLFS data
and is also the earliest year for which the US SSA cohort lifetables
are available. We also selected sibships with FLoSS≤−4.5 which
is approximately the lowest 2.2% of the FLoSS distribution among
the UPDB participants born after 1900 (the corresponding
sample is referred to as “UPDB-1900-AntiFLoSS”).
We note that this study cannot fully reproduce the LLFS
design and selection procedure (see Discussion) because, for
example, the latest birth cohort in the UPDB sample is
1910, therefore, there are no offspring of individuals born
after 1900 (which is the range of birth cohorts similar to
LLFS).
Computations for Cross-Sectional Time
Point
The wide range of birth cohorts available in the UPDB
sample allows selection of various cross-sectional time points
(referred to as “time points” or “years of study” in the
following text) for selection of “exceptional” families at such
time points and following their subsequent survival. Selecting
a time point closer to the LLFS baseline visit (which started
in 2006), i.e., using data on later birth cohorts, would provide
a better comparison with the LLFS probands’ generation
(the oldest generation in LLFS consisting of individuals from
“exceptional” families identified by FLoSS and their spouses).
However, this choice results in a smaller sample of individuals
surviving until that time point (due to a range of birth
cohorts limited by 1910 in the UPDB sample). Therefore,
we used earlier time points to allow the inclusion of more
individuals in the sample of survivors (see description in
Results).
For a specific year of study, we recalculated age and vital
status at this time point. That is, if year of death (or last known
living year) was after the year of study, then we assigned the
individual’s vital status as “alive” and computed his/her age
at this time point. We then selected all families with at least
one living individual aged 80 or above in the study year to
construct two subgroups, “exceptional” and “ordinary,” based on
the FLoSS. The “exceptional” group contained individuals who
were alive and aged 80 or above in the study year and belonged
to families with FLoSS ≥ 7. All other individuals who were alive
and aged 80 or above in the study year but were not selected in
the “exceptional” group comprised the “ordinary” group (which
would not be selected into LLFS).
We computed Kaplan-Meier estimates of the survival
functions for the “exceptional” and “ordinary” groups using
follow-up data onmortality for these individuals. Age at the study
year was used as the left truncation variable. The log-rank test was
used to evaluate the differences between survival curves.
Computations With Offspring of Parents
With “Exceptional” and “Ordinary” Survival
The UPDB sample is multi-generational which allows analyses
of survival patterns of offspring of parents with “exceptional”
and “ordinary” survival as identified by FLoSS. We constructed
two groups, the “exceptional offspring” group and the “ordinary
offspring” group. We identified “exceptional offspring” as
those who have either mother or father (or both) with
FLoSS ≥ 7 and “ordinary offspring” as those with both
parents from families with FLoSS < 7. We computed
the Kaplan-Meier estimates of the survival functions for
the “exceptional offspring” and “ordinary offspring” born
after 1900 using follow-up data on mortality for these
individuals.
All analyses were performed in SAS 9.4 and R 3.4.3. Graphical
output was prepared in R and MATLAB R2017b.
The study performs secondary analyses of previously collected
data. The study was approved by the Duke University
Campus Institutional Review Board (protocol C0027) and Duke
University Medical Center Institutional Review Board (protocol
10045).
RESULTS
Survival Exceptionality of UPDB-FLoSS
Sample
The FLoSS computation procedure was applied to the UPDB-
All sample to identify families with exceptional FLoSS (FLoSS
≥ 7). There were 799 families with 5,684 individuals selected
in the resulting UPDB-FLoSS sample. The average FLoSS in
the UPDB-All sample of 57,192 sibships was M = −0.234 and
standard deviation was S = 2.9. Supplementary Figure 1 shows
distributions of standardized FLoSS (S-FLoSS), computed as
S-FLoSS = (FLoSS-M)/S, in the UPDB-All and UPDB-FLoSS
samples. Supplementary Figure 2 presents distributions of age at
death for these samples.
Figure 1 displays survival curves for the UPDB-1900, the
UPDB-1900-FLoSS and the UPDB-1900-AntiFLoSS samples,
along with survival curves based on the US SSA 1900 cohort
life tables and the LLFS survival curves representing the Kaplan-
Meier curves (conditional at age 80) computed for subsets
of US participants of respective sex from the LLFS probands’
generation based on the study sample assessed on March 13,
2017. Figure 1 shows that the UPDB-1900-FLoSS participants
have survival that is very similar to the LLFS probands
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FIGURE 1 | Survival curves (conditional at age 80) for females (A) and males (B): (1) for all individuals from the UPDB sample born after 1900 (“UPDB-1900”); (2)
based on the US SSA 1900 cohort life tables (“SSA-1900”); (3) for individuals from UPDB-1900 with FLoSS ≥ 7 (“UPDB-1900-FLoSS”); (4) for individuals from
UPDB-1900 with FLoSS ≤ −4.5 (“UPDB-1900-AntiFLoSS”); (5) for the US participants from the probands’ generation in LLFS (“LLFS”).
FIGURE 2 | Kaplan-Meier estimates of survival functions for members of “exceptional” (“UPDB-y1980-E”) and “ordinary” (“UPDB-y1980-O”) groups for the study year
1980: (A) females and (B) males. The conditional survival curves (at age 80) computed from the US SSA 1900 cohort life tables (“SSA-1900”) are shown for
comparison.
whereas the entire UPDB-1900 sample has a conditional (at
age 80) survival curve that is also very similar to that of the
general US population. The UPDB-1900-AntiFLoSS sample has
substantially worse survival than the entire UPDB-1900 sample
as expected.
Calculations at a Single Time Point
We constructed “exceptional” and “ordinary” groups as
described in the Material and methods section for different time
points from 1900 to 2000. Because of the specifics of the UPDB
sample analyzed here (e.g., the maximal year of birth is 1910),
the number of living individuals aged 80 years and above reached
the maximum from the late 1970s to the early 1980s, decades
that also provide the maximum number of individuals in the
“exceptional” group. We selected 1980 as the representative
“study year” for this analysis. At this point, 15,144 individuals
were alive and 80 years or older and among those, 1,193 were
classified as the “exceptional” group and the remaining 13,951
formed the “ordinary” group (denoted UPDB-y1980-E and
UPDB-y1980-O, respectively).
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We followed both groups from year 1980 using the actual
years of death/censoring. Figure 2 presents the Kaplan-Meier
estimates of survival functions for the female and male members
of the “exceptional” and “ordinary” groups. The figure shows that
members of the “exceptional” group have better survival than the
members of the “ordinary” group (P < 0.0001 for both females
andmales). It also shows that the survival of the “ordinary” group
is quite similar to the US SSA 1900 cohort.
Computations With Offspring of Parents
With “Exceptional” and “Ordinary” Survival
We selected the “exceptional offspring” and the “ordinary
offspring” groups as described in the Material and methods
section for offspring born after 1900 (denoted “UPDB-1900-EO”
and “UPDB-1900-OO”, respectively). Altogether, 993 individuals
(502 females, 491 males) were selected in the “exceptional
offspring” group and 16,541 individuals (7,964 females, 8,577
males) were classified as the “ordinary offspring.” Among those,
587 (59.1%) “exceptional offspring” (347 females, 69.1%; 240
males, 48.9%) and 8,167 (49.4%) “ordinary offspring” (4,802
females, 60.3%; 3,365 males, 39.2%) survived until age 80.
Figure 3 shows survival functions (conditional on survival to
age 80) for the “exceptional offspring” group and the “ordinary
offspring” group born after 1900. The figure indicates that both
daughters (P < 0.0001) and sons (P = 0.0003) of parents from
the “exceptional” group have a survival advantage compared to
offspring of parents from the “ordinary” group. Survival of the
latter group is closer to that of the general population represented
by the SSA 1900 cohort.
DISCUSSION
The unique advantages of the UPDB, including its
comprehensive coverage of demographic data, extended sibship
sizes and a wide range of birth cohorts allowed us to illustrate
the potential benefit of using FLoSS as selection criteria in family
longevity studies. Using FLoSS computed from information on
lifespan in the UPDB sample, this study validated LLFS sample
selection procedure based on FLoSS to identify families with
exceptional longevity. Figure 1 illustrates that the subsample of
the UPDB participants born after 1900 who were from sibships
selected by the similar FLoSS threshold as in the LLFS (FLoSS
≥ 7) have survival curves (conditional on survival to age 80)
remarkably comparable to that of the US participants from the
LLFS probands’ generation and both curves lie to the right of the
“general” population curves (SSA and the full UPDB). We note
also that the entire UPDB sample has a survival curve similar
to that of the general US population despite the fact that Utah
has more individuals affiliated with the Church of Jesus Christ
of Latter-day Saints. These individuals generally do not use
tobacco or consume alcohol so they are expected to have better
survival. UPDB also includes fewer ethnic and racial groups who
historically have poorer survival. However, conditional survival
curves (at age 80) are presented here, therefore, any differences
in survival manifested at younger ages are not represented in
this figure. In addition, women in UPDB have more children
which can attenuate the survival benefits of being members of
the Church of Jesus Christ of Latter-day Saints. These and other
factors can contribute to the observed patterns of cohort life
expectancies in Utah and general populations [see discussion
in (6)].
This study is limited because we cannot fully reproduce the
LLFS enrollment procedure [see details, e.g., in Newman et al.
(7)] due to data availability and limited sample sizes of the
“exceptional” population. In LLFS, the proband was deemed
qualified for the enrollment in the study if he/she had at least
one living sibling and one offspring residing in the appropriate
catchment area. These criteria were needed to provide additional
relevant data for the analysis of phenotypic and genetic data.
However, such criteria are not applicable to the UPDB sample.
For example, the latest birth cohort is 1910 meaning that there
are no offspring of “probands” born after 1900 (which is the range
of birth cohorts similar to LLFS). Also, for FLoSS computations
in the UPDB sample, we constructed cohort lifetables using the
UPDB sample itself because SSA cohort lifetables (used in LLFS)
are not available for cohorts earlier than 1900.
The advantage of this study is that in the UPDB sample we are
able to locate the point in the distant past that yields the largest
“exceptional” samples and follow them using the available data
on mortality. Such computations in the UPDB sample further
confirmed (Figure 2) that the members of the “exceptional”
group (as defined by the FLoSS threshold) have better survival
at old (80+) ages than the members of the “ordinary” group (i.e.,
those not selected in the “exceptional” group). We note that since
age 80 is a more extreme survival threshold for men than for
women, the narrower gap between the curves for men than for
women in Figure 2may be a function of men being closer to their
maximum lifespan and hence having less room to improve upon
over the SSA/UPDB ordinary survival.
The availability of multiple generations in the UPDB sample
allowed us to compare survival of offspring of “exceptional” and
“ordinary” groups. Figure 3 demonstrates that daughters and
sons whose mothers and/or fathers are from the “exceptional”
group have better survival compared to offspring whose both
parents are from the “ordinary” group. However, the magnitude
of the differences in survival is smaller than that between the
“exceptional” and “ordinary” groups shown in Figure 2. This
observation confirms the findings in other studies which also
show that, in general, the correlation between the ages at death of
siblings is stronger than the correlation between the ages at death
of parents and children [see, e.g., (8, 9), among many others]. We
also note that Utah males have more lifestyle differences than
US males in general (relative to Utah females vs. US females)
which can contribute to the result shown in Figure 3where males
deviate more from the SSA “standard” than females.
Family longevity studies provide opportunities to investigate
relationships between various factors and longevity. The familial
structure requires using specific approaches in analyses of
such data. For example, frailty models can be used to analyze
multigenerational studies on longevity to assess effects of
unobserved environmental and genetic factors on longevity
(9). Availability of genetic information in familial studies on
longevity with follow-up information on mortality facilitates
finding associations between heritable genetic markers and
longevity. The studies show that using information on age
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FIGURE 3 | Kaplan-Meier estimates of survival functions (conditional at age 80) for offspring of parents with “exceptional” (“UPDB-1900-EO”) and “ordinary”
(“UPDB-1900-OO”) survival: (A) females (“daughters”) and (B) males (“sons”). The sample contains offspring born after 1900. The conditional survival curves (at age
80) computed from the US SSA 1900 cohort life tables (“SSA-1900”) are shown for comparison.
at biospecimen collection in addition to follow-up data on
mortality as well as incorporation of follow-up information
on non-genotyped individuals can give substantial increase in
power compared to analyses of follow-up data in genotyped
individuals alone (10, 11). Such approaches can be extended
to incorporate familial structure in the family longevity
studies. Dynamics of various biomarkers is related to mortality
and aging as the extensive literature documents (12) and
availability of longitudinal measurements of relevant biomarkers
in familial studies on longevity, coupled with appropriate
statistical approaches, can substantially advance our knowledge
on determinants of exceptional longevity.
This study demonstrates the value of familial and genealogical
microdata captured for entire populations spanning many
decades (13, 14). Increasingly these are available around the
world (e.g., Sweden, Netherlands, and Quebec) and can be
leveraged to identify families who are likely to harbor genetic
variants associated with extreme ages at death. Linkages
between these genealogies with comprehensive environmental
and epidemiological data are also occurring and can help to
sharpen the distinction between the influences of genetics and
socio-demographic factors on exceptional human survival.
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